CERo Therapeutics Holdings Inc. Watch

EX-10.2

from 8-K 24 pages Registration Rights Agreement

12/34/56

EX-10.1

from 8-K 69 pages Common Stock Purchase Agreement Dated as of November 8, 2024 by and Among CERo Therapeutics Holdings, Inc. and Keystone Capital Partners, LLC

12/34/56

EX-10.21

from S-1 6 pages Consent and Waiver Agreement

12/34/56

EX-10.20

from S-1 24 pages Registration Rights Agreement

12/34/56

EX-10.5

from 8-K 7 pages Consulting Agreement

12/34/56

EX-10.4

from 8-K 5 pages Consulting Agreement

12/34/56

EX-10.3

from 8-K 6 pages Consulting Agreement

12/34/56

EX-10.2

from 8-K 6 pages Consulting Agreement

12/34/56

EX-10.1

from 8-K 7 pages Consulting Agreement

12/34/56

EX-10.3

from 8-K 5 pages Consent and Waiver Agreement

12/34/56

EX-10.2

from 8-K 31 pages Registration Rights Agreement

12/34/56

EX-10.1

from 8-K 51 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) Would Likely Cause Competitive Harm to the Company if Disclosed. Securities Purchase Agreement

12/34/56

EX-10.17

from 10-K 8 pages CERo Therapeutics Holdings, Inc. March 28, 2024

12/34/56

EX-10.16

from 10-K 10 pages CERo Therapeutic Holdings, Inc. Executive Employment Agreement for Employee

12/34/56

EX-10.15

from 10-K 9 pages CERo Therapeutic Holdings, Inc. Executive Employment Agreement for Employee

12/34/56

EX-10.14

from 10-K 24 pages Registration Rights Agreement

12/34/56

EX-10.13

from 10-K 55 pages Securities Purchase Agreement

12/34/56

EX-10.1

from 8-K 30 pages Purchase Agreement

12/34/56

EX-10.12

from 8-K/A 2 pages February 14, 2024 Keystone Capital Partners, LLC 139 Fulton Street, Suite 412 New York, Ny 10038 Re: Phoenix Biotech Acquisition Corp. Dear Sir or Madam

12/34/56

EX-10.11

from 8-K/A 4 pages Letter Agreement

12/34/56